
Moxivib CV 1.2 Injection
Marketer
Vibcare Pharma Pvt Ltd
Salt Composition
Amoxycillin (1000mg) + Clavulanic Acid (200mg)
Overview Moxivib CV 1.2 Injection
Cefixime injection 1.2 mg, a penicillin-derivative antibiotic, combats bacterial infections. It's indicated for lung (pneumonia), ear, sinus, urinary tract, skin, and soft tissue infections; it's ineffective against viral illnesses like the common cold. Administration is exclusively by a healthcare provider; self-injection is prohibited. Dosage and frequency are determined by your physician based on your condition. Strict adherence to the prescribed regimen is crucial. Common adverse effects involve nausea, vomiting, diarrhea, and oral thrush; injection site reactions (pain, swelling, redness) may occur. Persistent or worsening symptoms warrant medical attention. Patients with severe liver or kidney impairment should consult their doctor prior to commencing treatment. Pre-treatment disclosure of antibiotic allergies or kidney/liver issues is essential; dosage adjustments or alternative medications may be necessary. Generally, it's considered safe for pregnant and breastfeeding individuals under medical guidance.
Uses of Moxivib CV 1.2 Injection
Preventing bacterial infections related to surgical procedures
Major Benefits of Moxivib CV 1.2 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Moxivib CV 1.2 Injection:
- Vomiting
- Nausea
- Diarrhea
- Thrush
How to use Moxivib CV 1.2 Injection:
Administering this medication will be handled by your physician or their nursing staff; self-medication is strictly prohibited.
How Moxivib CV 1.2 Injection works:
Moxivib CV 1.2 Injection merges amoxicillin, a bacterial growth inhibitor, with clavulanic acid, a beta-lactamase inhibitor. Amoxicillin's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. The addition of clavulanic acid overcomes bacterial resistance, thereby boosting amoxicillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from combining Moxivib CV 1.2 Injection with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The administration of Moxivib CV 1.2 Injection during pregnancy is typically deemed safe. Preclinical trials using animal models revealed minimal or absent harm to the fetus; nonetheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactational use of Moxivib CV 1.2 Injection is considered safe. Research in humans indicates negligible transfer into breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Administering Moxivib CV 1.2 Injection might result in adverse reactions impacting driving capabilities. These potential side effects include allergic responses, vertigo, or seizures, rendering individuals unsafe to operate a vehicle.
KidneyCAUTION
Caution is advised when administering Moxivib CV 1.2 Injection to individuals with impaired renal function. Dosage modifications for Moxivib CV 1.2 Injection might be necessary. Physician consultation is recommended. This medication is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Moxivib CV 1.2 Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised. Routine monitoring of liver function is recommended during treatment.
What if you forget to take Moxivib CV 1.2 Injection :
Should you forget a Moxivib CV 1.2 Injection, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed injection and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Moxivib CV 1.2 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
